Structure of a major immunogenic site on foot-and-mouth disease virus
Derek T. Logan(Stockholm University), Elizabeth E. Fry(University of Oxford), Stephen Curry(University of Nebraska–Lincoln), N. R. Parry(Wellcome Trust), Wendy Blakemore(The Pirbright Institute), Robin ABU-GHAZALEH(The Pirbright Institute), David I. Stuart(MRC Laboratory of Molecular Biology), Andrew King(The Pirbright Institute), Susan M. Lea(Frederick National Laboratory for Cancer Research), John W. Newman(National Institutes of Health), David J. Rowlands(University of Leeds), Terry Jackson(Unknown), Richard J. Lewis(AstraZeneca (Netherlands))
Cited by 366
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661